Kapasa Medizintechnik GmbH (Kapasamed) is an innovative Medical Technology Company focusing on developing medical devices and instruments.
Kapasa Medizintechnik GmbH manufactures medical devices that impact Public Health programs globally.
The company’s innovative product has led to the successful development and conduct of clinical trials of a male Circumcision Device, the Unicirc Surgical Assist Instrument.
The device has shown that it has the capacity to be safely used to impact the devastating effect of the Sub-Saharan HIV epidemic.
The device and the method of safe circumcision that has been developed with it’s use, can replace more than 80% of the current surgical circumcision method.
The Unicirc can substantially assist in reducing the backlog of circumcisions. UNAIDS have planned to circumcise at least 80% of 30 million males between the ages of 14 years and 49 years in Sub-Saharan Africa by 2021.
The Unicirc is used and distributed at this stage mainly in South Africa.
A circumcision with the Unicirc can be completed at a single visit, no needles and no sutures are needed for the circumcision procedure.
For further information about the Unicirc, please follow the link: www.unicircglobal.com